Holen Sie sich die Stockscreener-App
39.59
1.62%
0.63
Handel nachbörslich:
40.72
1.13
+2.85%
Schlusskurs vom Vortag:
$38.96
Offen:
$39.03
24-Stunden-Volumen:
4.08M
Relative Volume:
0.99
Marktkapitalisierung:
$17.11B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$1.66B
KGV:
17.24
EPS:
2.297
Netto-Cashflow:
$827.02M
1W Leistung:
-2.05%
1M Leistung:
+9.94%
6M Leistung:
+18.71%
1J Leistung:
+52.27%
1-Tages-Spanne:
$38.92
$40.00
1-Wochen-Bereich:
$38.39
$41.24
52-Wochen-Spanne:
$24.05
$41.24
Royalty Pharma Plc Stock (RPRX) Company Profile
Firmenname
Royalty Pharma Plc
Sektor
Branche
Telefon
(212) 883-0200
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Vergleichen Sie RPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
39.59 | 16.47B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.19 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.72 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.74 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.89 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
377.47 | 36.43B | 4.56B | -176.77M | 225.30M | -1.7177 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | Goldman | Buy |
| 2025-05-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-06-03 | Herabstufung | UBS | Buy → Neutral |
| 2022-06-14 | Fortgesetzt | UBS | Buy |
| 2022-05-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-30 | Eingeleitet | Tigress Financial | Buy |
| 2020-11-09 | Hochstufung | UBS | Neutral → Buy |
| 2020-07-14 | Eingeleitet | Evercore ISI | In-line |
| 2020-07-13 | Eingeleitet | BofA Securities | Buy |
| 2020-07-13 | Eingeleitet | Citigroup | Neutral |
| 2020-07-13 | Eingeleitet | Cowen | Outperform |
| 2020-07-13 | Eingeleitet | Goldman | Neutral |
| 2020-07-13 | Eingeleitet | JP Morgan | Neutral |
| 2020-07-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Eingeleitet | SunTrust | Buy |
| 2020-07-13 | Eingeleitet | UBS | Neutral |
Alle ansehen
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsQuarterly Investment Review & High Conviction Investment Ideas - newser.com
Why analysts remain bullish on Royalty Pharma plc stockBear Alert & Risk Managed Investment Strategies - newser.com
Can Royalty Pharma plc stock rebound after recent weakness2025 Key Highlights & Smart Swing Trading Alerts - newser.com
Analyzing net buyer seller activity in Royalty Pharma plcCEO Change & AI Based Buy and Sell Signals - newser.com
Is Royalty Pharma plc (RPD) stock attractive post correctionMarket Activity Report & Weekly Breakout Stock Alerts - newser.com
Ex-Dividend Reminder: Royalty Pharma, Cencora and MMM - Nasdaq
Will Royalty Pharma plc (RPD) stock maintain strong growthDip Buying & Safe Swing Trade Setups - newser.com
Bank of New York Mellon Corp Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Purchased by Aviva PLC - MarketBeat
Quantitative breakdown of Royalty Pharma plc recent move2025 Technical Overview & Community Consensus Picks - newser.com
What MACD signals say about Royalty Pharma plc2025 Bull vs Bear & Comprehensive Market Scan Reports - newser.com
Resona Asset Management Co. Ltd. Buys Shares of 110,430 Royalty Pharma PLC $RPRX - MarketBeat
Why retail investors pile into Royalty Pharma plc stockJuly 2025 Technicals & Weekly Breakout Stock Alerts - newser.com
Historical volatility pattern of Royalty Pharma plc visualizedJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Using Python tools to backtest Royalty Pharma plc strategies2025 Support & Resistance & Momentum Based Trading Signals - newser.com
Top chart patterns to watch in Royalty Pharma plc2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com
Royalty Pharma PLC $RPRX Shares Sold by Los Angeles Capital Management LLC - MarketBeat
Metis Global Partners LLC Acquires 30,959 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Applying chart zones and confluence areas to Royalty Pharma plcWeekly Earnings Recap & Daily Risk Controlled Trade Plans - newser.com
How Royalty Pharma plc (RPD) stock performs in easing cycles2025 Price Momentum & Community Driven Trade Alerts - newser.com
AGF Management Ltd. Has $3.36 Million Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Published on: 2025-11-10 02:13:10 - newser.com
Why Royalty Pharma plc (RPD) stock could outperform next yearVolume Spike & Real-Time Price Movement Reports - newser.com
(RPRX) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Achmea Investment Management B.V. Invests $1.23 Million in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Published on: 2025-11-07 09:50:08 - newser.com
Royalty Pharma Plc Hits New 52-Week High of $38.09 - Markets Mojo
A Look at Royalty Pharma’s (RPRX) Valuation Following Upgraded Guidance and Buybacks - Sahm
C WorldWide Group Holding A S Has $22.60 Million Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Position Increased by Bryn Mawr Trust Advisors LLC - MarketBeat
Royalty Pharma raises 2025 top line guidance to $3.2B–$3.25B amid strong portfolio expansion - MSN
Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Profit Report & AI Forecast Swing Trade Picks - newser.com
Is Royalty Pharma plc reversing from oversold territoryPortfolio Performance Summary & Consistent Growth Equity Picks - newser.com
Goldman Sachs raises Royalty Pharma stock price target to $45 on strong results By Investing.com - Investing.com South Africa
Goldman Sachs raises Royalty Pharma stock price target to $45 on strong results - Investing.com Australia
Royalty pharma to buy its external manager, announces $3B share buyback - MSN
What’s the recovery path for long term holders of Royalty Pharma plc2025 Performance Recap & Step-by-Step Swing Trade Plans - newser.com
Published on: 2025-11-06 05:49:05 - newser.com
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):